Besides, genetically predicted prostate cancer was not associated with IL-6 (β 0.002; 95% CI, -0.011, 0.014; P=0.755) levels in the meta-analysis and sensitivity analyses (Figure 5 and Supplementary Table 10). The gene discussed is IL6; the disease is Familial prostate cancer.